Harbert Fund Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,300
Closed -$4.74M 45
2023
Q1
$4.74M Buy
+10,300
New +$4.9M 3.13% 9

Other funds holding ELV

Harbert Fund Advisors's ELV Position: Q2 2025 in Review

Harbert Fund Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 2,850 shares — an estimated $1.24M sold.

Harbert Fund Advisors first reported a position in ELV in Q2 2022 and held it in 9 quarters. The position peaked at $3.12M in Q2 2024. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Harbert Fund Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Harbert Fund Advisors sold 2,850 Elevance Health shares in Q2 2025, an estimated $1.24M.
  • Harbert Fund Advisors first reported a position in Elevance Health in Q2 2022 and held it in 9 quarters.
  • Harbert Fund Advisors's Elevance Health position peaked at $3.12M in Q2 2024.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Harbert Fund Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.